Complete Story
 

04/11/2013

ICLUSIG (ponatinib) Now Approved

ICLUSIG (ponatinib) is a kinase inhibitor indicated for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) READ MORE